Format

Send to

Choose Destination
Seizure. 2018 Apr;57:1-4. doi: 10.1016/j.seizure.2018.02.013. Epub 2018 Mar 2.

Ehlers-Danlos syndromes and epilepsy: An updated review.

Author information

1
Department of Clinical Sciences and Community Health, University of Milan, IRCCS Ca' Granda Foundation, Milan, Italy; Genetics Laboratory, IRCCS Ca' Granda Foundation, Milan, Italy.
2
School of Medicine and Surgery, University of Milano-Bicocca, via Cadore 48, 20900 Monza, Italy. Electronic address: chiara.villa@unimib.it.

Abstract

The Ehlers-Danlos syndromes (EDS) comprise a clinically and genetically heterogeneous group of heritable connective tissue disorders (HCTDs), characterised by joint hypermobility, hyperextensibility of the skin and tissue fragility that can induce symptoms from multiple organ systems. The latest EDS nosology distinguished thirteen subtypes with an overlap of phenotypic features, making the clinical diagnosis rather difficult and highlighting the importance of molecular diagnostic confirmation. Although the nervous system is not considered a primary target of the underlying molecular defect, recently, increasing attention has been focused on neurological manifestations of EDS. Among them, epilepsy represents a frequent cause of morbidity in these syndromes and can influence the long-term evolution of these patients, but the mechanisms are needed to be clarified. The aim of this review is to give a comprehensive overview and to analyze a possible association between EDS and epilepsy, focusing on the various brain anomalies and the types of epilepsy reported in patients affected by EDS.

KEYWORDS:

Ehlers-Danlos syndromes; Epilepsy; Genetics; Seizure

PMID:
29499446
DOI:
10.1016/j.seizure.2018.02.013
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center